Stryker
SYK
About: Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
Employees: 53,000
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
50% more first-time investments, than exits
New positions opened: 162 | Existing positions closed: 108
48% more call options, than puts
Call options by funds: $672M | Put options by funds: $454M
14% more repeat investments, than reductions
Existing positions increased: 896 | Existing positions reduced: 789
8% more capital invested
Capital invested by funds: $111B [Q1] → $120B (+$9.23B) [Q2]
1.59% more ownership
Funds ownership: 77.93% [Q1] → 79.53% (+1.59%) [Q2]
1% more funds holding
Funds holding: 2,199 [Q1] → 2,215 (+16) [Q2]
2% less funds holding in top 10
Funds holding in top 10: 84 [Q1] → 82 (-2) [Q2]
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
5 analyst ratings
Rothschild & Co
Ed Ridley-Day
|
$420
|
Neutral
Initiated
|
18 Sep 2025 |
Truist Securities
Richard Newitter
|
$415
|
Hold
Maintained
|
4 Aug 2025 |
Wells Fargo
Larry Biegelsen
|
$445
|
Overweight
Maintained
|
1 Aug 2025 |
Needham
Mike Matson
|
$448
|
Buy
Maintained
|
1 Aug 2025 |
Evercore ISI Group
Vijay Kumar
|
$415
|
Outperform
Maintained
|
8 Jul 2025 |
Financial journalist opinion
Based on 7 articles about SYK published over the past 30 days